Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HLA-DOA | GDSC1000 | pan-cancer | AAC | -0.26 | 8e-10 |
mRNA | HBB | CCLE | pan-cancer | AAC | 0.29 | 9e-10 |
mRNA | NHLRC4 | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-10 |
mRNA | ARG1 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | FAM124B | CCLE | pan-cancer | AAC | 0.31 | 1e-09 |
mRNA | TUBAL3 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | PABPC1 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
mRNA | GLUL | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | OSM | CCLE | pan-cancer | AAC | 0.32 | 1e-09 |
mRNA | TAS2R5 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |